The primary goal of this Phase 2 clinical trial is to determine the effects of a novel V1a receptor antagonist (NTX-1472) in adults with Social Anxiety Disorder (SAD). The main questions this trial aims to answer are: * Is NTX-1472 safe and well tolerated in adults with SAD? * How effectively does NTX-1472 treat adults with SAD? Researchers will compare the effects of NTX-1472 with matching placebo (a look-alike capsule that contains no drug). Participants will: * Take NTX-1472 or matching placebo every day for 8 weeks * Visit the clinic 6 times over the course of 14 weeks for checkups and tests
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
100
Daily (QD) x 8 weeks.
Daily (QD) x 8 weeks.
SOAR Clinical Study Site
Pheonix, Arizona, United States
RECRUITINGSOAR Clinical Study Site
Encino, California, United States
RECRUITINGSOAR Clinical Study Site
Los Angeles, California, United States
RECRUITINGSOAR Clinical Study Site
Oceanside, California, United States
RECRUITINGSOAR Clinical Study Site
San Jose, California, United States
RECRUITINGSOAR Clinical Study Site
Jacksonville, Florida, United States
RECRUITINGSOAR Clinical Study Site
Tampa, Florida, United States
RECRUITINGSOAR Clinical Study Site
Boston, Massachusetts, United States
RECRUITINGSOAR Clinical Study Site
Brooklyn, New York, United States
RECRUITINGSOAR Clinical Study Site
Memphis, Tennessee, United States
RECRUITING...and 1 more locations
Incidence and severity of treatment-emergent adverse events (TEAEs)
Time frame: Baseline to Week 8
Change in the clinician-administered Liebowitz Social Anxiety Scale (LSAS) total score
The Liebowitz Social Anxiety Scale (LSAS) is a clinician-administered scale that is designed to record the severity of subjective anxiety and avoidance behavior across a range of social interaction and performance situations. The fear and avoidance subscale scores range from 0 to 72 each. The total score ranges from 0 to 144. Higher scores indicate greater severity of social anxiety.
Time frame: Baseline to Week 8
Change in LSAS Fear/Anxiety and Avoidance subscale score
The Liebowitz Social Anxiety Scale (LSAS) is a clinician-administered scale that is designed to record the severity of subjective anxiety and avoidance behavior across a range of social interaction and performance situations. The fear and avoidance subscale scores range from 0 to 72 each. The total score ranges from 0 to 144. Higher scores indicate greater severity of social anxiety.
Time frame: Baseline to Week 8
Number and percentage of participants who are responders (≥50% improvement from Baseline [Day 1]) based on the LSAS total score
The Liebowitz Social Anxiety Scale (LSAS) is a clinician-administered scale that is designed to record the severity of subjective anxiety and avoidance behavior across a range of social interaction and performance situations. The fear and avoidance subscale scores range from 0 to 72 each. The total score ranges from 0 to 144. Higher scores indicate greater severity of social anxiety.
Time frame: Baseline to Week 8
Number and percentage of participants who are remitters based on an LSAS total score of <30
The Liebowitz Social Anxiety Scale (LSAS) is a clinician-administered scale that is designed to record the severity of subjective anxiety and avoidance behavior across a range of social interaction and performance situations. The fear and avoidance subscale scores range from 0 to 72 each. The total score ranges from 0 to 144. Higher scores indicate greater severity of social anxiety.
Time frame: Baseline to Week 8
Change in Hamilton Anxiety Rating Scale (HAM-A) total score
The Hamilton Anxiety Rating Scale (HAM-A) is a clinician-administered scale that is designed to rate severity of anxiety. The total score ranges from 0 to 56. Higher scores indicate greater severity of anxiety.
Time frame: Baseline to Week 8
Clinical Global Impression - Severity (CGI-S) score
The Clinical Global Impression - Severity (CGI-S) score is rated on a 7-point scale, using a range of responses from 1 (normal, not at all ill) through to 7 (among the most extremely ill patients).
Time frame: Baseline to Week 8
Patient Global Impression - Severity (PGI-S) score
The Patient Global Impression - Severity (CGI-S) score is rated on a 7-point scale, using a range of responses from 1 (not present) through to 7 (extremely severe).
Time frame: Baseline to Week 8
Change in Depression Anxiety Stress Scale - 21 items (DASS-21, Stress subscale only)
The Depression Anxiety Stress Scale - 21 items (DASS-21), Stress subscale ranges from 0 to 21, with higher scores indicating greater stress severity.
Time frame: Baseline to Week 8
Change in University of California, Los Angeles Loneliness Scale 10-items (UCLA LS 10) score
The University of California, Los Angeles Loneliness Scale 10-items (UCLA LS 10) score ranges from 10 to 40, with higher scores indicating greater perceived loneliness.
Time frame: Baseline to Week 8
Change in Pittsburgh Sleep Quality Index (PSQI) global score
The Pittsburgh Sleep Quality Index (PSQI) global score ranges from 0 to 21, with higher scores indicating worse sleep quality.
Time frame: Baseline to Week 8
Change in State-Trait Anxiety Inventory (STAI) state
The State-Trait Anxiety Inventory (STAI) state score ranges from 20 to 80, with higher scores indicating greater anxiety in the moment.
Time frame: Baseline to Week 8
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.